Gates Foundation
Facts
- HQ
- Washington, D.C.
- Sectors
- Philanthropy, Global health, International development, Non-profit
- Founded
- 2000
- Employees
- 500
A-Alpha Bio wins $620,472 NSF Phase II SBIR to develop molecular-glue discovery system
Seattle startup A-Alpha Bio received a $620,472 NSF Phase II SBIR grant to develop a system that identifies molecular glues which tag disease-causing proteins for cellular degradation, aiming to target previously 'undruggable' proteins for diseases like Alzheimer’s, cancer and autoimmune disorders.
NextStep raises $3.6M to scale mobile training and job-placement for displaced workers into healthcare roles
Seattle startup NextStep raised $3.6 million to expand its mobile training and job-placement platform that recruits and trains displaced, low-wage workers for in-demand healthcare roles like CNAs and home health aides.
Foursquare and Factual merge under Foursquare brand with David Shim named CEO; Sue Desmond-Hellmann joins Pfizer board
Foursquare and Factual are merging under the Foursquare brand with Placed founder David Shim as CEO; Sue Desmond-Hellmann joined Pfizer’s board after leaving the Gates Foundation, and other executive moves include Microsoft hiring Rubén Caballero and leadership change at Egencia.
Guide for Startup Founders: COVID-19 Health Guidance, $1T Global Economic Risk, and Relief Measures from Governments and Tech Leaders
This article compiles guidance and curated resources for startup founders and small business owners navigating the COVID-19 crisis, covering health advice from WHO/CDC, economic warnings like the UN's $1 trillion hit estimate, and policy responses from governments and private-sector advisors such as Sequoia Capital and Founder Institute. It highlights industry impacts (e.g., food service, events, hospitality) and directs entrepreneurs to government, NGO, and corporate relief measures and recommendations.
Seattle’s A-Alpha Bio Raises $2.8M Seed Round to Advance AlphaSeq Drug Discovery Platform
Seattle startup A-Alpha Bio raised $2.8 million in seed funding to advance its genetically engineered protein analysis platform, AlphaSeq, which accelerates drug candidate evaluation by sorting millions of protein interactions. The round was led by OS Fund and included investors such as Madrona Venture Group and AME Cloud Ventures.
People
-
Bill Gates Founder, Co-founder and Co-chair
-
Melinda French Gates Founder, Co-founder and Co-chair, Former Co-chair
